Discover the latest April 2025 update on Dow Dogs! Learn about top investment picks, forecasted gains, and market corrections ...

Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.

Merck , known as MSD outside of the United States and Canada, will hold its first-quarter 2025 sales and earnings conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, ...

Designed to provide broad exposure to the Small Cap Value segment of the US equity market, the JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) is a passively managed exchange traded fund ...

Merck dazzled with Phase 3 trial results for its PAH drug WINREVAIR, but the market responded with a collective shrug, ...

Levi & Korsinsky, LLP notifies investors in Perpetua Resources Corp. ("Perpetua Resources Corp." or the "Company") of a class action securities ...

Many investor eyes were on the pharmaceutical industry on Tuesday, and not necessarily for the right reasons. The Trump ...

New York, New York-- (Newsfile Corp. - April 1, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, ...

Learn more about whether Corcept Therapeutics Incorporated or Merck & Co., Inc. is a better investment based on AAII's A+ ...

Learn more about whether Jazz Pharmaceuticals plc or Merck & Co., Inc. is a better investment based on AAII's A+ Investor ...

June E-mini S&P futures (ESM25) are up +0.38%, and June E-mini Nasdaq futures (NQM25) are up +0.81%. Stock indexes recovered from early losses on Tuesday and finished higher mainly due to the strength ...

Major drugmakers were trading sharply lower on Tuesday as Wall Street is bracing for a broader set of tariffs that President ...